Dr. Namandjé N. Bumpus @DrBumpusFDA Twitter profile

Pinned Tweet

Dr. Namandjé N. Bumpus

1 year

At every step of my career, I was told I would not get to the next, so as I continue along my career journey, it is so important to me to remove barriers and bolster as many young scientists as I can. Thank you @HHSGov for sharing my story.

U.S. FDA

@US_FDA

1 year

Dr. Namandjé Bumpus, FDA's Chief Scientist, shares her story about speaking out against bias, breaking the glass ceiling, and helping guide the careers of others. #NMHM2023 @DrBumpusFDA

6

14

34

9

7

20

Last Seen Profiles

@Pecintastw4050

@ktcapuchin

@CoachRhoades15

@CPVillarrobledo

@ogikosyowaltz

@coach_D_lincoln

@simmons74margar

@UNinPalestine

@CoachMaui

@jandakembangstw

@Stephens16T

@helenknows

@AdangDerrick

@Marius_Krason

@Lm10Messista

@UNFBBALL

@MyPrideZeeNunew

@KappaSigmaHQ

@myspacemai

@infiniteorbs

@_1zqy

@NewentDrama

@yuahamuchan

@ssd_kichi

@miraichan_cos

@Tante_giranggg

@MrDeriv

@_H1maz1n1

@frozen_umbrella

@thomas_diew

@verge

@O_ANT_2

@Officialdess7

@upvoty

@PerryAritua

@PeterKe67945662

Dr. Namandjé N. Bumpus Retweeted

U.S. FDA

@US_FDA

9 hours

Check out the latest FDA Roundup, our at-a-glance summary of agency updates: Friday, we announced the opening of a new period for applications for grants to support the development and potential approval or conditional approval of new animal drugs

4

5

Dr. Namandjé N. Bumpus Retweeted

U.S. FDA

@US_FDA

4 days

Check out the latest FDA Roundup, our at-a-glance summary of agency updates: Yesterday, we announced Medline Industries, LP, a firm marketing and distributing plastic syringes made in China within the U.S., initiated a recall to stop using affected

14

4

12

Dr. Namandjé N. Bumpus Retweeted

U.S. FDA

@US_FDA

7 days

Check out the latest FDA Roundup, our at-a-glance summary of agency updates: Today, we announced registration is open for the two-day virtual public meeting, "FDA’s Fifth Online Controlled Substances Summit." We also announced we

4

6

3

Dr. Namandjé N. Bumpus Retweeted

U.S. FDA

@US_FDA

8 days

Today is Clinical Trials Day! We remain committed to supporting clinical research including engaging patients and caregivers to understand their unique perspectives to promote innovative clinical trial design. #FDAVoices

FDA Promotes Clinical Trial Innovation

As the FDA observes Clinical Trials Day, we reflect on the progress made and the widespread efforts underway to advance clinical trial innovation.

www.fda.gov

4

21

37

Dr. Namandjé N. Bumpus Retweeted

U.S. FDA

@US_FDA

11 days

Check out the latest FDA Roundup, our at-a-glance summary of agency updates: Yesterday, we granted accelerated approval to a treatment for extensive stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy.

14

4

5

Dr. Namandjé N. Bumpus Retweeted

U.S. FDA

@US_FDA

14 days

Check out the latest FDA Roundup, our at-a-glance summary of agency updates: Yesterday, FDA’s Office of Science and Engineering Laboratories launched an improved online Regulatory Science Tool Catalogto enhance search and browse capability as well as

3

6

Dr. Namandjé N. Bumpus Retweeted

U.S. FDA

@US_FDA

19 days

In today's episode of FDA In Your Day, we discuss the 50th biosimilar approval, High Blood Pressure Awareness Month, a new medical device initiative and more!

1

11

15

Dr. Namandjé N. Bumpus Retweeted

U.S. FDA

@US_FDA

18 days

Check out the latest FDA Roundup, our at-a-glance summary of agency updates: Yesterday, we provided information on how to safely charge hearing aids, glucose monitors, insulin pumps, and other medical devices to avoid overheating.

9

3

8

Dr. Namandjé N. Bumpus Retweeted

U.S. FDA

@US_FDA

21 days

Check out the latest FDA Roundup, our at-a-glance summary of agency updates: Today we announced a meeting of the Psychopharmacologic Drugs Advisory Committee on June 4 to discuss a new drug application for midomafetamine (MDMA) capsules, submitted by

7

6

14

Dr. Namandjé N. Bumpus Retweeted

Michael Felberbaum

@FDASpox

27 days

New today: @FDACBER 's Dr. Peter Marks is among @TIME 's list of the 100 Most Influential People in global health.

Peter Marks

Find out why Peter Marks is on the TIME100 Health list.

time.com

3

5

10

Dr. Namandjé N. Bumpus Retweeted

U.S. FDA

@US_FDA

28 days

Check out the latest FDA Roundup, our at-a-glance summary of agency updates: Today the FDA, in coordination with the U.S. Department of Justice (DOJ), announced that the U.S. Marshals Service seized unauthorized e-cigarette products valued at more than

5

3

7

Dr. Namandjé N. Bumpus Retweeted

U.S. FDA

@US_FDA

1 month

Check out the latest FDA Roundup, our at-a-glance summary of agency updates: Today, we published the FDA Voices: A Milestone in Facilitating the Development of Safe and Effective Biosimilars. Also today, we announced that we’ve

10

4

10

Dr. Namandjé N. Bumpus

@DrBumpusFDA

1 month

Check out episode 3 of FDA In Your Day! Today, we talk about National Drug Takeback Day, National Minority Health Month, and counterfeit Botox.

6

4

Dr. Namandjé N. Bumpus

@DrBumpusFDA

1 month

I’m delighted to welcome the children of our wonderful FDA staff to our headquarters this morning! We’ve planned several activities for them during our combined Bring Your Child to Work Day and Earth Day Celebration! I hope to share more photos today!

0

2

10

Dr. Namandjé N. Bumpus

@DrBumpusFDA

1 month

I was honored to help kick off a two-day bilateral meeting between the FDA and our EU counterparts at our headquarters today. Throughout the visit, we’ll be focusing on future opportunities for cooperation on both food and medical product matters.

6

7

18

Dr. Namandjé N. Bumpus Retweeted

U.S. FDA

@US_FDA

1 month

Check out the latest FDA Roundup, our at-a-glance summary of agency updates: Today, we announced a new initiative aimed to help reimagine the home environment as an integral part of the health care system. The Home as a Health Care Hub is intended to

6

4

11

Dr. Namandjé N. Bumpus Retweeted

U.S. FDA

@US_FDA

1 month

Check out the latest FDA Roundup, our at-a-glance summary of agency updates: On Thursday, we posted a safety communication to inform the public and healthcare providers that the agency has required and approved labeling changes to the U.S. Prescribing

10

2

8